Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. short communication
  4. article
Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells
Download PDF
Download PDF
  • Short Communication
  • Open access
  • Published: 01 October 2005

Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells

  • Hye-Won Lim1,
  • Suntaek Hong,
  • Wook Jin,
  • Seunghwan Lim,
  • Su-Jung Kim,
  • Hyun-Jung Kang,
  • Eun-Hee Park,
  • Kisup Ahn &
  • …
  • Chang-Jin Lim 

Experimental & Molecular Medicine volume 37, pages 497–506 (2005)Cite this article

  • 1557 Accesses

  • 40 Citations

  • Metrics details

Abstract

Reactive oxygen species (ROS) are involved in a diversity of important phenomena in the process of tumor development. To investigate the alterations of oxidative stress and their related systems in tumor progression, a variety of components in the antioxidative stress defense system were examined in prostate cancer cell lines, PC3 and LNCaP. Cell surface molecules involved in metastasis were expressed highly in PC3 cells compared with LNCaP cells, and strong invasion ability was shown in PC3 cells only. ROS level in LNCaP cells was twice higher than that in PC3 cells, although nitric oxide (NO) level was similar between the two cell lines. The content of GSH increased up to about 2-fold in PC3 compared with LNCaP. Activities of glutathione reductase, thioredoxin reductase, and glutathione S-transferase except catalase are significantly higher in PC3 cells than in LNCaP cells. Furthermore, oxidative stress-inducing agents caused down-regulation of GSH and glutathione S-transferase much more significantly in LNCaP cells than in PC3 cells. These results imply that malignant tumor cells may maintain low ROS content by preserving relatively high anti-oxidative capacity, even in the presence of stressful agents.

Similar content being viewed by others

Oxidative cell death in cancer: mechanisms and therapeutic opportunities

Article Open access 01 August 2024

Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis

Article Open access 16 February 2021

Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer

Article Open access 15 May 2024

Article PDF

Author information

Authors and Affiliations

  1. Division of Life Sciences, Kangwon National University, Chuncheon, 200-701, Korea

    Hye-Won Lim

Authors
  1. Hye-Won Lim
    View author publications

    Search author on:PubMed Google Scholar

  2. Suntaek Hong
    View author publications

    Search author on:PubMed Google Scholar

  3. Wook Jin
    View author publications

    Search author on:PubMed Google Scholar

  4. Seunghwan Lim
    View author publications

    Search author on:PubMed Google Scholar

  5. Su-Jung Kim
    View author publications

    Search author on:PubMed Google Scholar

  6. Hyun-Jung Kang
    View author publications

    Search author on:PubMed Google Scholar

  7. Eun-Hee Park
    View author publications

    Search author on:PubMed Google Scholar

  8. Kisup Ahn
    View author publications

    Search author on:PubMed Google Scholar

  9. Chang-Jin Lim
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Lim, HW., Hong, S., Jin, W. et al. Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells. Exp Mol Med 37, 497–506 (2005). https://doi.org/10.1038/emm.2005.62

Download citation

  • Published: 01 October 2005

  • Issue date: 01 October 2005

  • DOI: https://doi.org/10.1038/emm.2005.62

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • catalase
  • glutathione
  • glutathione reductase
  • glutathione S-transferase
  • metastasis
  • oxidative stress
  • prostatic neoplasms
  • thioredoxin

This article is cited by

  • A heterometallic ruthenium–gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer

    • Benelita T. Elie
    • Yuriy Pechenyy
    • María Contel

    JBIC Journal of Biological Inorganic Chemistry (2018)

  • Blood and tissue nitric oxide and malondialdehyde are prognostic indicators of localized prostate cancer

    • Meltem Ozlen Dillioglugil
    • Haluk Mekık
    • Ozdal Dillioglugil

    International Urology and Nephrology (2012)

  • Association of Pb, Cd, and Se Concentrations and Oxidative Damage-Related Markers in Different Grades of Prostate Carcinoma

    • Savas Guzel
    • Lebriz Kiziler
    • Haydar Durak

    Biological Trace Element Research (2012)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited